aod9604 fat loss efficacy clinical trials side effects AOD-9604 Safety Profile: What Show AOD-9604 vs MOTS-c vs Tesamorelin

This product is neither a drug, food, nor cosmetic, and must not be misrepresented, misused, or mislabeled as such

Those with significant fat loss goals Individuals with 50+ pounds to lose may benefit from extended protocols with strategic breaks rather than aggressive dosing

While AOD-9604 has shown minimal interactions in studies, individual situations vary, particularly when multiple medications are involved

Water fluctuations, muscle changes, and timing of measurements create noise that obscures actual fat loss

Signs your dose needs adjustment Increase dose consideration: Minimal response after 3-4 weeks at current dose, stable weight and measurements despite consistent protocol adherence, absence of any subjective improvements in energy or fasted tolerance